Skip to content

Comparison of the Efficacy of Rebixiao Chinese Herbal Tablets and Chinese Formula Granules in Treating Acute Gout Arthritis: A Randomized, Double-Blind, Multicenter, Controlled Trial

Comparison the clinical efficacy between 'Clearing heat and promoting diuresis' Chinese Herbal Tablets and Chinese Formula Granules treating Acute Gout Arthritis

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016527
Enrollment
Unknown
Registered
2018-06-06
Start date
2018-06-10
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Gout

Interventions

Group 1:Rebixiao Chinese Herbal Tablets
Group 2:Chinese Formula Granules

Sponsors

Chongqing Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Between the ages of 18 and 65 years; (2) According to the classification criteria for acute gout developed by the American rheumatism association in 1977; (3) According to the criteria for the diagnosis of gout and the classification of syndromes, compiled by the Department of Medical and political Affairs of the State Administration of traditional Chinese Medicine in 1995, the criteria for the diagnosis of gout are as follows: acute gout with dampness and heat accumulation syndrome; (4) Gout attacks within 48h of screening; (5) the most painful joint was defined as the index joint, and the degree of pain in the index joint was at least moderate or was greater than 2 points on a Likert scale; (6) informed consent was obtained.

Exclusion criteria

Exclusion criteria: (1) chronic gouty arthritis stage; (2) clinical suspicion of joint infection or other joint disease; (3) polyarticular gout involving more than four joints; (4) pregnancy, preparation for pregnancy or breast-feeding; (5) liver disease activity or abnormal liver function; (6) upper limit of normal value of blood creatinine; (7) abnormal reduction of white blood cells, hemoglobin or platelets on routine blood tests, or other diseases of the blood system; (8) coronary heart disease, heart failure, gastrointestinal hemorrhage, or a history of peptic ulcer; (9) use of non-steroidal anti-inflammatory drugs (NSAIDs) or corticosteroids within 48 h before the baseline assessments; (10) allergic to any of the study drugs; (11) and mental illness or mental disorder.

Design outcomes

Primary

MeasureTime frame
pain;swelling of joint;redness of joint;fever of joint;The TCM symptom scale comprised seven items: upset;The TCM symptom scale comprised seven items: thirst;The TCM symptom scale comprised seven items: scanty dark urine;

Secondary

MeasureTime frame
The erythrocyte sedimentation rate;The level of C-reactive protein;

Countries

China

Contacts

Public ContactYanping Li

Chongqing Hospital of Traditional Chinese Medicine

840051779@qq.com+86 13983105519

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026